Enliven Therapeutics, Inc. ELVN
Set alert
44.63 USD +0.38 +0.86%
At close · Nov 2
44.63 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
43.23 Day range 45.06
14.79 52-week range 62.32
- YTD
- +189.81%
- 1 year
- +90.56%
- Open
- 44.48
- Prev close
- 44.25
- Mkt cap
- 3.27B
- Vol
- 1.14M
- Avg vol
- 1.36M
- EPS
- -1.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 43.23
- High
- 45.06
- Forward P/E
- -19.26
- Beta
- 0.36
- Short ratio
- 5.98
- Inst. own
- 115.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 48.70
- 200-d avg
- 42.73
- 1y target
- 74.42
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 74.42 +66.7% upside
Now 44.63
- Target (low)
- 69.00
- Target (mean)
- 74.42
- Target (high)
- 82.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy3
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.4522 | -0.52 – -0.38 | -0.32 | -41.3% | 0 | 0.0% | 8 |
| Next quarter | -0.56594 | -0.69 – -0.46 | -0.48 | -17.9% | 0 | 0.0% | 7 |
| Current year | -1.91 | -2.55 – -1.38 | -1.83 | -4.6% | 0 | 0.0% | 8 |
| Next year | -2.32 | -2.60 – -1.94 | -1.91 | -21.1% | 5.00K | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 2, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Oct 1, 2026 | JP Morgan | Initiated | — | Overweight |
| Aug 18, 2026 | William Blair | Initiated | — | Outperform |
| Aug 18, 2026 | Barclays | Initiated | — | Overweight |
| Aug 18, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 6, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 21, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 9, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 1, 2026 | Stifel | Maintained | Buy | Buy |
| Jun 29, 2026 | Jones Trading | Maintained | Buy | Buy |
| Jun 9, 2026 | Stifel | Initiated | — | Buy |
| Jun 2, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 8, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 26, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 2, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 16, 2025 | Goldman Sachs | Initiated | — | Buy |
| Jun 16, 2025 | Baird | Maintained | Outperform | Outperform |
| May 16, 2025 | Jones Trading | Maintained | Buy | Buy |
| May 15, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 21, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 13, 2024 | BTIG | Initiated | — | Buy |
| Nov 15, 2024 | Baird | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Jones Trading | Initiated | — | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 9, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Jun 11, 2024 | Baird | Initiated | — | Outperform |